, a bio/informatics shared resource is still "open for business" - Visit the CDS website

  1. Pancreatic β-cell-specific ablation of TASK-1 channels augments glucose-stimulated calcium entry and insulin secretion, improving glucose tolerance. Dadi PK, Vierra NC, Jacobson DA (2014) Endocrinology 155(10): 3757-68
    › Primary publication · 24932805 (PubMed) · PMC4164933 (PubMed Central)
  2. Inhibition of pancreatic β-cell Ca2+/calmodulin-dependent protein kinase II reduces glucose-stimulated calcium influx and insulin secretion, impairing glucose tolerance. Dadi PK, Vierra NC, Ustione A, Piston DW, Colbran RJ, Jacobson DA (2014) J Biol Chem 289(18): 12435-45
    › Primary publication · 24627477 (PubMed) · PMC4007438 (PubMed Central)
  3. ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload. Egnatchik RA, Leamy AK, Jacobson DA, Shiota M, Young JD (2014) Mol Metab 3(5): 544-53
    › Primary publication · 25061559 (PubMed) · PMC4099508 (PubMed Central)
  4. Direct activation of β-cell KATP channels with a novel xanthine derivative. Raphemot R, Swale DR, Dadi PK, Jacobson DA, Cooper P, Wojtovich AP, Banerjee S, Nichols CG, Denton JS (2014) Mol Pharmacol 85(6): 858-65
    › Primary publication · 24646456 (PubMed) · PMC4014665 (PubMed Central)
  5. β-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion. Kaihara KA, Dickson LM, Jacobson DA, Tamarina N, Roe MW, Philipson LH, Wicksteed B (2013) Diabetes 62(5): 1527-36
    › Primary publication · 23349500 (PubMed) · PMC3636652 (PubMed Central)
  6. Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels. Baerenwald DA, Bonnefond A, Bouatia-Naji N, Flemming BP, Umunakwe OC, Oeser JK, Pound LD, Conley NL, Cauchi S, Lobbens S, Eury E, Balkau B, Lantieri O, MAGIC Investigators, Dadi PK, Jacobson DA, Froguel P, O'Brien RM (2013) Diabetologia 56(6): 1306-16
    › Primary publication · 23508304 (PubMed) · PMC4106008 (PubMed Central)
  7. Ion channels and regulation of insulin secretion in human β-cells: a computational systems analysis. Fridlyand LE, Jacobson DA, Philipson LH (2013) Islets 5(1): 1-15
    › Primary publication · 23624892 (PubMed) · PMC3662377 (PubMed Central)
  8. G6PC2: a negative regulator of basal glucose-stimulated insulin secretion. Pound LD, Oeser JK, O'Brien TP, Wang Y, Faulman CJ, Dadi PK, Jacobson DA, Hutton JC, McGuinness OP, Shiota M, O'Brien RM (2013) Diabetes 62(5): 1547-56
    › Primary publication · 23274894 (PubMed) · PMC3636628 (PubMed Central)
  9. The physiological effects of deleting the mouse SLC30A8 gene encoding zinc transporter-8 are influenced by gender and genetic background. Pound LD, Sarkar SA, Ustione A, Dadi PK, Shadoan MK, Lee CE, Walters JA, Shiota M, McGuinness OP, Jacobson DA, Piston DW, Hutton JC, Powell DR, O'Brien RM (2012) PLoS One 7(7): e40972
    › Primary publication · 22829903 (PubMed) · PMC3400647 (PubMed Central)
  10. Channeling dysglycemia: ion-channel variations perturbing glucose homeostasis. Denton JS, Jacobson DA (2012) Trends Endocrinol Metab 23(1): 41-8
    › Primary publication · 22134088 (PubMed) · PMC3733341 (PubMed Central)